We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
1776
Visa
V
$684B
– –
-10,780
Closed -$515K
VHC icon
1777
VirnetX Holding Corp
VHC
$54.4M
– –
-575
Closed -$235K
VLGEA icon
1778
Village Super Market
VLGEA
$651M
– –
-12,605
Closed -$479K
VMI icon
1779
Valmont Industries
VMI
$9.3B
– –
-2,128
Closed -$296K
VNDA icon
1780
Vanda Pharmaceuticals
VNDA
$307M
– –
-10,212
Closed -$112K
VNET
1781
VNET Group
VNET
$2.04B
– –
-12,400
Closed -$204K
VRTX icon
1782
Vertex Pharmaceuticals
VRTX
$121B
– –
-23,055
Closed -$1.75M
VTR icon
1783
Ventas
VTR
$48B
– –
-3,090
Closed -$217K
WBD icon
1784
Warner Bros
WBD
$65.9B
– –
-7,204
Closed -$311K
WBS icon
1785
Webster Financial
WBS
$12.5B
– –
-10,718
Closed -$274K
WHF icon
1786
WhiteHorse Finance
WHF
$137M
– –
-11,600
Closed -$175K
WLK icon
1787
Westlake Corp
WLK
$9.03B
– –
-12,174
Closed -$637K
WSO icon
1788
Watsco Inc
WSO
$12.7B
– –
-3,234
Closed -$305K
XOMA
1789
DELISTED
Xoma
XOMA
– –
-515
Closed -$46K
ZG icon
1790
Zillow
ZG
$7.94B
– –
-11,715
Closed -$329K
ONIT
1791
Onity Group
ONIT
$309M
– –
-1,357
Closed -$1.14M
SUNE
1792
SUNation Energy
SUNE
$8.95M
– –
0
– -$131K
NPKI
1793
NPK International
NPKI
$1.06B
– –
-37,837
Closed -$479K
QVCGA
1794
DELISTED
QVC Group Inc Series A
QVCGA
– –
-1,252
Closed -$1.21M
BERY
1795
DELISTED
Berry Global Group, Inc.
BERY
– –
-13,402
Closed -$246K
BECN
1796
DELISTED
Beacon Roofing Supply, Inc.
BECN
– –
-8,753
Closed -$323K
B
1797
DELISTED
Barnes Group Inc.
B
– –
-5,972
Closed -$209K
HAYN
1798
DELISTED
Haynes International, Inc.
HAYN
– –
-6,153
Closed -$279K
SPWR
1799
DELISTED
SunPower Corporation Common Stock
SPWR
– –
-26,985
Closed -$462K
SLCA
1800
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
– –
-39,377
Closed -$980K
70 71
72
73 74

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.